Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

05.10.06	Accenture and Edge Dynamics Launch Next Phase of Channel Commerce Management Initiative for Bristol-Myers Squibb (PR Newswire)
28.09.06	Crohn's & Colitis Foundation of America and ConvaTec Announce 2006 Great Comebacks Regional Awards Recipients (PR Newswire)
12.09.06	Bristol-Myers Squibb Board of Directors Announces Departure of Peter R. Dolan as CEO and Appointment of James M. Cornelius as Interim CEO (PR Newswire)
16.08.06	Program Leaders Outline Effective Strategies for Fighting HIV/AIDS in Children in Resource-Limited Settings (PR Newswire)
16.08.06	Program Leaders Outline Effective Strategies for Fighting HIV/AIDS in Children in Resource-Limited Settings (PR Newswire)
31.07.06	Ausblick: Die Märkte am Montag (Aktiencheck)
27.07.06	Bristol-Myers Squibb Company Reports Financial Results for the Second Quarter and First Half of 2006 (PR Newswire)
28.06.06	FDA Approves SPRYCEL(TM) (dasatinib) With Two Indications (PR Newswire)
23.05.06	96-Week Viral Suppression Data From Two Studies Presented for BARACLUDE(R) (entecavir) in Chronically-Infected Hepatitis B Patients (PR Newswire)
02.03.06	FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck Cancer; First and Only Approved Monoclonal Antibody for Squamous Cell Carcinoma of the Head and Neck (Businesswire)
28.02.06	U.S. Food and Drug Administration Approves EMSAM(R) (selegiline transdermal system), the First Transdermal Patch for the Treatment of Major Depressive Disorder (PR Newswire)
24.02.06	Eröffnung des ersten medizinischen Zentrums für an HIV/AIDS erkrankte Kinder in Swasiland; Aufbau von Behandlungskapazitäten in dem am härtesten getroffenen Land der Welt (PR Newswire)
24.02.06	Swaziland's First Children's HIV/AIDS Medical Center Opens; Building Treatment Capacity in the World's Hardest Hit Country (PR Newswire)
25.01.06	Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2005 and Announces EPS Guidance for 2006 (PR Newswire)
23.01.06	Crohn's Patient Robert Hill Reaches Peak of Antarctica's Tallest Mountain (PR Newswire)
18.01.06	FDA Grants Priority Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack (PR Newswire)
09.01.06	Bristol-Myers Squibb and Gilead Announce Data Supporting Bioequivalence for Single-Pill Fixed-Dose Regimen of Sustiva(R) (efavirenz) and Truvada(R) (emtricitabine and tenofovir disoproxil fumarate) (Businesswire)
27.12.05	Wall Street-Schluss: Anleihen treiben US-Märkte in den Keller (n/a)
13.12.05	PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective Cardiovascular Risk Reduction Treatment for Patients With Established Peripheral Arterial Disease (P.A.D.) (PR Newswire)
05.12.05	Domantis Announces Therapeutic Alliance with Bristol-Myers Squibb (PR Newswire)
14.11.05	BARACLUDE(TM) (entecavir) Two-year Data Analysis Did Not Detect Emergence of Resistance in Nucleoside-Naive Chronic Hepatitis B Patients (PR Newswire)
31.10.05	Merck und Bristol-Myers Squibb lizenzieren neue AIDS-Medikamente an IPM zur Entwicklung von Mikrobiziden zum Schutz von Frauen vor HIV (PR Newswire)
28.10.05	Bristol-Myers Squibb Company Reports Financial Results for the Third Quarter and First Nine Months of 2005, Reflecting Ongoing Investments in Strategy Aimed at Delivering Sustainable Growth (PR Newswire)
24.10.05	Ausblick: Die Märkte am Montag (n/a)
19.09.05	Walgreens Acquires the Rights to Theragran-M Multivitamins (PR Newswire)
09.09.05	Bristol-Myers Squibb and Merck Joint Statement on FDA Advisory Committee Vote on PARGLUVA(TM) (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes (PR Newswire)
06.09.05	Bristol-Myers Squibb Statement on FDA Advisory Committee Vote on ORENCIA(R) (Abatacept), an Investigational Selective Modulator of T-Cell Co-Stimulation for Rheumatoid Arthritis (PR Newswire)
20.05.05	New Study Shows Investigational Compound Muraglitazar Significantly Lowered Blood Glucose Levels As Measured By A1C Reduction in Patients With Type 2 Diabetes (PR Newswire)
28.04.05	Elixir Pharmaceuticals Licenses Novel Growth Hormone Secretagogue Comp (Businesswire)
28.04.05	Wichtige US-Quartalszahlen vom 28.04.2005 (n/a)
12.04.05	FDA fordert Black Box-Warnung für sieben Antidepressiva (n/a)
27.01.05	Wichtige US-Quartalszahlen vom 27.01.2005 (n/a)
13.01.05	Sod-Turning Ceremony Marks Start of Construction of First Pediatric HI (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

29.11.24		Pluszeichen in New York: Letztendlich Gewinne im Dow Jones
29.11.24		Starker Wochentag in New York: Dow Jones mit Kursplus
29.11.24		Gute Stimmung in New York: Börsianer lassen Dow Jones mittags steigen
29.11.24		SMI-Handel aktuell: SMI zum Handelsende auf grünem Terrain
29.11.24		Börse Zürich in Grün: SLI letztendlich in der Gewinnzone
29.11.24		Börse Europa: Anleger lassen STOXX 50 zum Handelsende steigen
29.11.24		Gewinne in Europa: Euro STOXX 50 präsentiert sich zum Ende des Freitagshandels fester
29.11.24		NYSE-Handel: Dow Jones verbucht zum Start Gewinne

29.11.24

Pluszeichen in New York: Letztendlich Gewinne im Dow Jones

29.11.24

Starker Wochentag in New York: Dow Jones mit Kursplus

29.11.24

Gute Stimmung in New York: Börsianer lassen Dow Jones mittags steigen

29.11.24

SMI-Handel aktuell: SMI zum Handelsende auf grünem Terrain

29.11.24

Börse Zürich in Grün: SLI letztendlich in der Gewinnzone

29.11.24

Börse Europa: Anleger lassen STOXX 50 zum Handelsende steigen